Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| glutamatergic neuron | 7 studies | 31% ± 17% | |
| epithelial cell | 6 studies | 30% ± 11% | |
| neuron | 5 studies | 25% ± 10% | |
| endothelial cell | 5 studies | 23% ± 4% | |
| retinal ganglion cell | 4 studies | 61% ± 29% | |
| GABAergic neuron | 4 studies | 38% ± 7% | |
| abnormal cell | 4 studies | 18% ± 2% | |
| CD4-positive, alpha-beta T cell | 3 studies | 17% ± 2% | |
| non-classical monocyte | 3 studies | 28% ± 11% | |
| retinal bipolar neuron | 3 studies | 20% ± 4% | |
| B cell | 3 studies | 16% ± 1% | |
| amacrine cell | 3 studies | 28% ± 13% | |
| fibroblast | 3 studies | 20% ± 5% | |
| enteroendocrine cell | 3 studies | 22% ± 8% | |
| basal cell | 3 studies | 23% ± 9% | |
| goblet cell | 3 studies | 19% ± 2% | |
| interneuron | 3 studies | 29% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| liver | 100% | 4031.17 | 226 / 226 | 100% | 66.43 | 406 / 406 |
| ovary | 100% | 6756.49 | 180 / 180 | 100% | 82.79 | 430 / 430 |
| prostate | 100% | 5636.38 | 245 / 245 | 100% | 96.10 | 502 / 502 |
| skin | 100% | 6597.09 | 1809 / 1809 | 100% | 107.47 | 472 / 472 |
| stomach | 100% | 4747.29 | 359 / 359 | 100% | 56.04 | 286 / 286 |
| esophagus | 100% | 4714.33 | 1444 / 1445 | 100% | 52.29 | 183 / 183 |
| brain | 100% | 9945.99 | 2640 / 2642 | 100% | 132.58 | 705 / 705 |
| kidney | 100% | 6196.38 | 89 / 89 | 100% | 101.35 | 900 / 901 |
| thymus | 100% | 7203.40 | 653 / 653 | 100% | 113.47 | 604 / 605 |
| breast | 100% | 5614.24 | 459 / 459 | 100% | 94.93 | 1116 / 1118 |
| pancreas | 100% | 3941.20 | 327 / 328 | 100% | 70.90 | 178 / 178 |
| lung | 100% | 4834.95 | 577 / 578 | 100% | 67.47 | 1153 / 1155 |
| uterus | 100% | 5807.26 | 170 / 170 | 100% | 57.26 | 457 / 459 |
| intestine | 100% | 5608.93 | 966 / 966 | 99% | 60.02 | 524 / 527 |
| adrenal gland | 100% | 6845.90 | 258 / 258 | 99% | 93.60 | 228 / 230 |
| bladder | 100% | 5724.71 | 21 / 21 | 99% | 57.55 | 499 / 504 |
| adipose | 100% | 5323.69 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 100% | 145.89 | 80 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 60.20 | 29 / 29 |
| peripheral blood | 100% | 7367.26 | 929 / 929 | 0% | 0 | 0 / 0 |
| spleen | 100% | 5771.72 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 63.80 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 57.18 | 1 / 1 |
| blood vessel | 100% | 5033.86 | 1334 / 1335 | 0% | 0 | 0 / 0 |
| heart | 93% | 2271.80 | 801 / 861 | 0% | 0 | 0 / 0 |
| muscle | 86% | 2135.83 | 692 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0007029 | Biological process | endoplasmic reticulum organization |
| GO_0061709 | Biological process | reticulophagy |
| GO_0030574 | Biological process | collagen catabolic process |
| GO_0016020 | Cellular component | membrane |
| GO_0005789 | Cellular component | endoplasmic reticulum membrane |
| GO_0140506 | Molecular function | endoplasmic reticulum-autophagosome adaptor activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | RETREG2 |
| Protein name | Reticulophagy regulator 2 Reticulophagy regulator family member 2 |
| Synonyms | FAM134A C2orf17 MAG2 |
| Description | FUNCTION: Endoplasmic reticulum (ER)-anchored autophagy regulator which exists in an inactive state under basal conditions but is activated following cellular stress . When activated, induces ER fragmentation and mediates ER delivery into lysosomes through sequestration into autophagosomes via interaction with ATG8 family proteins . Required for collagen quality control in a LIR motif-independent manner (By similarity). . |
| Accessions | C9J3K5 C9JIF3 ENST00000452293.5 ENST00000430297.7 ENST00000452022.1 F8WAL5 F8WE68 ENST00000273048.2 H7C3D5 ENST00000420189.1 Q8NC44 ENST00000458520.5 |